Gillessen, S, Gallardo, E, Choudhury, A, Saad, F, Soares, A, Loriot, Y, McDermott, R, Rodriguez-Vida, A, Velho, PI, Nolè, F, Cruz, F, Roumeguere, T, Daugaard, G, Yamamura, R, Bompas, E, Maroto, P, Veiga, FG, Skoneczna, I, da Trindade, KM, Carcano, FM, Lecouvet, F, Coens, C, Poncet, C, Fournier, B, Tombal, B. Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer. ANNALS OF ONCOLOGY. 2026; 37(5)DOI:10.1016/j.annonc.2026.02.009. PMID:41763609. IF:65.400(Q1/1D).

Yaringaño, J, Mirallas, O, Navarro, V, Gómez-Puerto, D, Velilla, G, Vaz, MA, Gorria, T, Martínez-Monino, A, Hernández, A, Aguado, M, Di Muzio, A, Valbuena, DL, Ruiz-Pace, F, González, M, Martínez-García, M, Villacampa, G, Balaña, C, Carles, J, Dienstmann, R, Pineda, E, Sepúlveda, JM, Vieito, M. Progression-Free Survival 2 as a Potential Surrogate for Overall Survival in Glioblastoma: Insights From a Spanish Multicentric Cohort. Cancer Medicine. 2026; 15(4)DOI:10.1002/cam4.71825. PMID:42002922. IF:3.100(Q2/5D).

Gámez-Pozo, A, Trilla-Fuertes, L, Becerril-Gómez, F, Lalanda-Delgado, P, Soriano, V, Goldaraz, FG, Lecumberri, MJ, de la Borbolla, MR, Majem, M, Pérez-Ruiz, E, González-Cao, M, Oramas, J, López-Vacas, R, Magdaleno, A, Fra, J, Martín-Carnicero, A, Corral, M, Puértolas, T, Ramos-Ruiz, R, Espinosa, E, Vara, JAF. Immune classification of advanced melanoma identifies non-responders to anti-PD1 therapy. CANCER IMMUNOLOGY IMMUNOTHERAPY. 2026; 75(5)DOI:10.1007/s00262-026-04392-1. PMID:42047827. IF:5.100(Q1/3D).

Herrera, IC, Cols, LC, Pijuan-Andujar, L, Cajo, SA, Montalvan, RG, Calvente, MG, Luque, GA, Gallardo, A, Jaramillo, JFC. Impact of Cell-Free TNA Fraction on Analytical Success in Liquid Biopsy for Lung Adenocarcinoma: Experience from a Tertiary Hospital. LABORATORY INVESTIGATION. 2026; 106(3)DOI:10.1016/j.labinv.2025.105990. PMID:. IF:4.200(Q1/1D).

D'Angelo, E, Kingsley, LG, Espinosa, I, Cipriani, V, Marotta, A, Nasr, S, Zdravkovic, S, Howitt, BE, Prat, J. Mullerian adenosarcoma of the uterus, ovary and peritoneum: Whole transcriptomic digital spatial profiling (DSP) in a cohort of 42 tumors. HUMAN PATHOLOGY. 2026; 173DOI:10.1016/j.humpath.2026.106117. PMID:41932512. IF:2.600(Q2/4D).

Misad, C, Cajo, SA, Espadaler, I, Muñoz, R, D'Angelo, E, Gallardo, A, Espinosa, I, Prat, J. Serous Tubal Intraepithelial Carcinoma (STIC): Incidence and Clinical Implications in 254 Consecutive Cases from a Tertiary Care Hospital. LABORATORY INVESTIGATION. 2026; 106(3)DOI:10.1016/j.labinv.2025.105314. PMID:. IF:4.200(Q1/1D).

Rodríguez-Fraga, P, Cascos, E, Cuartas, A, Espadaler, I. Cardiac plasmacytoma with extensive infiltration: multimodal diagnosis and therapeutic challenges: a case report. European Heart Journal-Case Reports. 2026; 10(2)DOI:10.1093/ehjcr/ytag102. PMID:41728229. IF:(Q/D).

Bruixola, G, Martín-Arana, J, Vidales, Z, Peon, G, Gimeno-Valiente, F, Tous, S, Camblor, DG, Cirauqui, B, García-Bartolomé, M, Sumarroca, A, Martínez-Castedo, B, Leon, X, Micó-García, B, Iglesias-Martínez, B, García-March, A, Segui, V, Pavón, MA, Quirós, B, Clavero, O, Maroñas, M, Escorihuela-Garcia, V, Tarazona, N, Alemany, L, Oliva, M. ctDNA clearance after induction therapy as predictor of response to radical chemoradiotherapy in locally advanced head and neck cancer. RADIOTHERAPY AND ONCOLOGY. 2026; 216DOI:. PMID:. IF:5.300(Q1/2D).

Hosseinzadeh, F, Zanoni, D, França, PDD, Valero, C, Peterson, G, Ardigo, M, Ghossein, R, Dusza, SW, Pillarsetty, N, Kose, K, Wong, RJ, Ganly, I, Rajadhyaksha, M, Patel, SG. Artificial Intelligence-Assisted reflectance confocal microscopy for Real-Time intraoperative margin assessment in oral squamous cell carcinoma. ORAL ONCOLOGY. 2026; 177DOI:10.1016/j.oraloncology.2026.107939. PMID:41932031. IF:3.900(Q1/2D).

Sumarroca, A, Vega, C, López, S, Leidinger, A, Pedemonte, G, León, X, Costa-González, JM. Lower lip reconstruction with the Karapandzic flap or the Colmenero flap: Description of results. Acta Otorrinolaringologica Espanola. 2025; 76(2)DOI:10.1016/j.otorri.2024.10.001. PMID:39923991. IF:(Q/D).

Moreno, EG, Pizarro, MPV, Dotu, CO, Martínez, AL, Escalante, JEM, Beltran, JD. Cochlear implant failures and complications: What should radiologists look for?. Radiologia. 2026; 68(2)DOI:10.1016/j.rx.2025.501685. PMID:. IF:(Q/D).

Schjesvold, F, Spencer, A, Cohen, YC, Ocio, EM, Lopez-Pardo, J, Cafro, AM, Callander, NS, Kaufman, JL, Mohan, M, Wermke, M, Doki, N, Kan, RBC, Milanez-Almeida, P, Stein, A, Trabucco, G, Ye, S, Kulec, K, Sechaud, R, Banerjee, S, Zhong, HQ, Lai, CT, Rauch, PJ, Raab, MS. Final clinical data of a phase 1 dose-escalation study of WVT078, a BCMA×CD3 bispecific antibody, alone and in combination with ?-secretase inhibitor WHG626 in patients with relapsed and/or refractory multiple myeloma. CANCER. 2026; 132(7)DOI:10.1002/cncr.70341. PMID:41880322. IF:5.100(Q1/3D).

Cesaro, S, Garonzi, C, Tridello, G, Verheggen, I, Liu, DH, Flynn, C, Alahmari, A, Kaynar, L, Rabitsch, W, Uygun, V, Chorao, P, Hu, J, Esquirol, A, Piñana, JL, Aljurf, M, Wagner-Drouet, E, Lang, PT, Martin-Sanchez, G, Ratip, S, Facchini, L, Nasilowska-Adamska, B, Styczynski, J, Ram, R, Metafuni, E, Tanase, A, Kalwak, K, Serio, B, Hashem, H, Castagna, L, Vicent, MG, Karakukcu, M, Halahleh, K, Baltadakis, I, Benedetti, E, Mikulska, M, de la Camara, R, Averbuch, D. Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT. BONE MARROW TRANSPLANTATION. 2026; 61(5)DOI:10.1038/s41409-026-02832-1. PMID:41888297. IF:5.200(Q1/1D).

García-Cadenas, I, Guerreiro, M, Yañez, L, Chorao, P, Martin, F, Suárez-Lledó, M, Pérez, A, Tomás, LG, López, J, Marsal, J, Romero, N, Huguet, M, Zabalza, A, González-Vicent, M, Vázquez, L, Silva, P, Gil, D, Micó-Cerdà, M, Sánchez, P, Filaferro, S, Balsalobre, P, Jiménez-Ubieto, A, Martino, R, Piñana, JL. Evolving Patterns of EBV-Associated PTLD After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter GETH-TC Study. EUROPEAN JOURNAL OF HAEMATOLOGY. 2026; 116(4)DOI:10.1111/ejh.70109. PMID:41502050. IF:2.300(Q2/5D).

Mikulska, M, Tridello, G, Ljungman, P, Styczynski, J, Averbuch, D, Cesaro, S, Knelange, N, Wendel, L, Piñana, JL, Popova, M, Kröger, N, Sengeloev, H, Besley, C, Labussiere-Wallet, H, Yegin, ZA, Greco, R, Baron, F, Yonal-Hindilerden, I, Xhaard, A, Metafuni, E, Verbeek, M, Byrne, J, Toprak, SK, Grassi, A, Vallisa, D, Clay, J, Bufarull, RM, Van Gorkom, G, Sevindik, OG, Wilson, K, de la Camara, R. Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study. BONE MARROW TRANSPLANTATION. 2026; 61(4)DOI:10.1038/s41409-026-02819-y. PMID:41795056. IF:5.200(Q1/1D).

Hidalgo-Soto, M, Rodríguez-Lobato, LG, Borrella, CM, Cayuela, AS, Pardo, JL, Rosiñol, L, Cibeira, MT, García-Guiñon, A, Tolosa-Ridao, C, Arostegui, IC, Sureda, A, Herranz, MJ, Montreal, EA, Pelicano, M, Alzuria, YB, Sansa, MC, Gironella, M, González, Y, De Larrea, CF. Pomalidomide, Cyclophosphamide and Dexamethasone (PCd): Outcomes in Patients With Double- or Triple-Refractory Multiple Myeloma. EUROPEAN JOURNAL OF HAEMATOLOGY. 2026; 116(6)DOI:10.1111/ejh.70126. PMID:41652820. IF:2.300(Q2/5D).

Habib, AA, Sacconi, S, Antonini, G, Cortés-Vicente, E, Grosskreutz, J, Mahuwala, ZK, Mantegazza, R, Pascuzzi, RM, Utsugisawa, K, Vissing, J, Vu, T, Wiendl, H, Boehnlein, M, Greve, B, Woltering, F, Bril, V. Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study. Therapeutic Advances in Neurological Disorders. 2024; 17DOI:10.1177/17562864241273036. PMID:39297052. IF:4.100(Q1/2D).

Domínguez, JMG, Villar, LM, Arrambide, G, Blanco, Y, Calles, MC, Casanova, B, Castillo-Triviño, T, França, LCF, Eichau, S, Pérez, MAH, Landete, L, Lallana, JM, Oreja-Guevara, C, Prieto, JM, Querol, L, Caminero, AB. Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases. NEUROLOGIA. 2026; 41(4)DOI:10.1016/j.nrl.2025.501928. PMID:. IF:3.100(Q2/4D).

Kleefeld, F, Gamboa, JT, Pinal-Fernandez, I, Preusse, C, Nelke, C, Goebel, HH, Mensch, A, Mossakowski, A, Miah, MU, Diaz-Manera, J, Torchia, E, Bortolani, S, Hentschel, A, Funke, A, Souvannanorath, S, Authier, FJ, Malfatti, E, Gehrig, J, Mammen, AL, Casal-Dominguez, M, De Winter, J, De Ridder, W, Ruck, T, Schneider, U, Roos, A, Gallardo, E, Tasca, G, Stenzel, W. Brachio-cervical inflammatory myopathy: multilevel clinical, histopathological and multi-omic analyses of a syndrome variably associated with systemic sclerosis. ACTA NEUROPATHOLOGICA. 2026; 151(1)DOI:10.1007/s00401-026-03006-5. PMID:41934478. IF:9.300(Q1/1D).

Cortés-Vicente, E, Guerrero, A, Díaz, C, Martínez, E, Toja-Camba, FJ, Abad, MR, Serra, JM, Trillo, JL, Machín, CM, Gil, A. Assessing the Value Contribution of Vyvgart® (Efgartigimod Alfa) in the Treatment of Generalized Myasthenia Gravis with Acetylcholine Receptor Antibody in Spain Through Multi-criteria Decision Analysis. ADVANCES IN THERAPY. 2026; 43(4)DOI:10.1007/s12325-026-03490-x. PMID:41591648. IF:4.000(Q1/3D).